Status:
TERMINATED
Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention
Lead Sponsor:
Massachusetts General Hospital
Conditions:
De Quervain Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates a Decision Aid to help patients with de Quervain's tenosynovitis decide how to treat their condition. For patients with symptoms of depression, half the participants will receive...
Detailed Description
The investigators are doing this research to see if they can improve the management of patients with de Quervain's tendinopathy. In the first part of this study, a Decision Aid (DA) has been developed...
Eligibility Criteria
Inclusion
- Adults (≥18 years) diagnosed with de Quervain's tenosynovitis
- English fluency and literacy
- Ability to give informed consent
Exclusion
- Inability or unwillingness to participate in decision aid (DA) and/or Toolkit-depression
- Major medical comorbidity expected to worsen in the next 6 months
- Comorbid chronic pain condition
- Antidepressant medications changes in the past 6 months
- Severe and untreated mental health conditions or active substance dependence
- Secondary gains such as litigations or worker compensation procedures that may interfere with patients' motivation for treatment
- No online device available to use the DA and Toolkit-depression
Key Trial Info
Start Date :
December 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 19 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04069741
Start Date
December 10 2018
End Date
February 19 2022
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hand and Arm Center, Massachusetts General Hospital
Boston, Massachusetts, United States, 02114